Tina Wang

Biotechnology Research Center, Cuixi Academy of Biotechnology, Zhuji, 311800, China
Author    Correspondence author
Cancer Genetics and Epigenetics, 2024, Vol. 12, No. 1   doi: 10.5376/cge.2024.12.0001
Received: 20 Nov., 2023    Accepted: 21 Dec., 2023    Published: 01 Jan., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Wang T., 2024, The application prospects of immunomodulators in cancer treatment, Cancer Genetics and Epigenetics, 12(1): 1-7 (doi: 10.5376/cge.2024.12.0001)

Cancer is a significant global health issue with increasing incidence and mortality rates. Traditional cancer treatment methods, including surgical removal, radiotherapy, and chemotherapy, have achieved some efficacy to a certain extent but still pose many limitations and side effects. Therefore, finding new treatment strategies has become a focal point in current cancer research. Immune modulators, as a novel approach to cancer treatment, have the characteristics of regulating the immune system and enhancing the body's immune response, showing promising results in clinical practice. However, there is currently some controversy and uncertainty regarding the prospects of immune modulators in cancer treatment. Thus, this review aims to summarize the application prospects of immune modulators in cancer treatment, explore their mechanisms of action, clinical application status, and development trends, providing a reference for further research and clinical practice.

Immune modulators; Cancer treatment; Immune system; Body immune response; Development trends